-The Hindu Business Line A mint-fresh working paper by the Reserve Bank of India once again trains the spotlight on a problem that, for five decades, every policy-maker has planned to snuff out, failed to, and then wished it would go away if ignored. But financial exclusion simply hasn't, and we now have the central bank applying its forensic skills to an examination of its magnitude. The title of Working Paper Series...
More »SEARCH RESULT
Assamese students study for only 2.3 hours compared to 6 hours in other States: NCERT
-The Hindu Students in government schools in Assam study only for two-and-a-half hours every day at the primary level compared to five-and-a-half to six-and-a-half hours in the rest of the country, an official study has shown. Similarly, the total number of working days in primary schools each year is 180 in Nagaland and Manipur and a maximum of 253 in Bihar and Jharkhand with lower than average literacy rates. But in most...
More »Government to increase bonds value for rural medical service to Rs 5L and Rs 10L
-The Times of India GANDHINAGAR: Nitin Patel, state health and family welfare minister said that the state goverment has decided to take a Rs 5 lakh bond from students at government-funded colleges. This is as security to ensure they serve three years in rural areas. Those who do not serve in rural areas after their studies will have to forfeit the amount. Earlier the amount was only Rs 1.5 lakh, so...
More »Health gap between countries is narrowing, but challenges remain–UN report
-The United Nations The health gap between poor and rich countries has narrowed significantly over the past two decades according to a United Nations report released today, which stresses that in spite of this progress, challenges still remain to achieve the health targets of the Millennium Development Goals (MDGs). "Intensive efforts to achieve the MDGs have clearly improved health for people all over the world," said the Director-General of the World Health...
More »Ranbaxy fined $500 m for flawed generics-Narayan Lakshman
-The Hindu Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S. The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came...
More »